An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)

por Wang, Huai-Yu, Gong, Sha, Li, Guo-Hui, Yao, Ya-Zhou, Zheng, Yin-Suo, Lu, Xiao-Hong, Wei, Su-Hua, Qin, Wei-Wei, Liu, Hai-Bo, Wang, Meng-Chang, Xi, Jie-Ying, Chen, Li-Mei, Zhang, Mei, Zhang, Xin-Xin, Zhang, Hui-Yun, Zhang, Cheng-Sheng, Wald, David N., Zhu, Hong-Hu, Liu, Li, He, Peng-Cheng
Publicado 2022